Background
Maternal vitamin D status during pregnancy and lactation is a modifiable factor that may influence offspring musculoskeletal outcomes. However, few randomized trials have tested the effects of prenatal or postpartum vitamin D supplementation on offspring bone and muscle development.
Objective
To examine hypothesized effects of improvements in early-life vitamin D status on childhood musculoskeletal health in Dhaka, Bangladesh.
Design
In a previously-completed double-blind dose-ranging trial, healthy pregnant women (n = 1300) were recruited at 17-24 weeks’ gestation and randomized to a prenatal; postpartum regimen of 0;0, 4200;0, 16800;0, 28000;0 or 28000;28000 IU cholecalciferol (vitamin D3)/week until 26 weeks postpartum. In this new report, we describe additional follow-up at 4 years of age (n = 642) for longer-term outcomes. Bone mineral content (BMC) and areal density (aBMD) were measured by dual-energy X-ray absorptiometry. Grip strength was tested using a hand-held dynamometer. The primary comparison was children of women assigned to 28000 IU/week prenatally versus placebo. Differences were expressed as means and 95% confidence intervals (95% CIs).
Results
Total-body-less-head (TBLH) BMC, TBLH aBMD, and grip strength were similar in the combined high-dose prenatal (28000;0 and 28000;28000 IU/week) versus placebo groups (mean difference [95% CI] = 0.61g [-10.90, 12.13], 0.0004g/cm2 [-0.0089, 0.0097] and 0.02kg [-0.26, 0.31] respectively). In dose-ranging analyses, TBLH BMC and aBMD, whole body (WB) BMC and aBMD, and grip strength in each of the prenatal vitamin D groups were not significantly different from placebo (P>0.05 for all comparisons). Only head aBMD was greater in children of women assigned to the 28000;28000 IU regimen versus placebo (mean difference [95% CI] = 0.024g/cm2 [0.0009, 0.047], P = 0.042); the effect was attenuated upon adjustment for child height, weight, and sex (P = 0.11).
Conclusions
Maternal prenatal, with or without postpartum, vitamin D supplementation does not improve child BMC, aBMD or grip strength at 4 years of age.
Trial registration: www.clinicaltrials.gov NCT03537443